Marks discusses CAR-Ts, CRISPR and START at regenerative medicine meeting
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyChemistry, Manufacturing and Controls (CMC)Clinical TrialsRegulatory Intelligence/PolicyUnited States